ACT Lung Health Intervention: Phase Two
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
George Washington University
Wake Forest University Health Sciences
Milton S. Hershey Medical Center
Dartmouth-Hitchcock Medical Center
University of Colorado, Denver
Dana-Farber Cancer Institute
VA Office of Research and Development
Dana-Farber Cancer Institute
Wake Forest University Health Sciences
Medical University of South Carolina
University of Wisconsin, Madison
Chinese University of Hong Kong
University of Utah
Washington University School of Medicine
H. Lee Moffitt Cancer Center and Research Institute
Norwegian Institute of Public Health
M.D. Anderson Cancer Center
University of Oregon
Abramson Cancer Center at Penn Medicine
Medical University of Bialystok
American College of Radiology
Massachusetts General Hospital
Yale University
Royal Marsden NHS Foundation Trust
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Abramson Cancer Center at Penn Medicine
University of California, San Francisco
University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
University of Manchester
Masonic Cancer Center, University of Minnesota
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Hospital St. Joseph, Marseille, France
Yale University
H. Lee Moffitt Cancer Center and Research Institute
Spectrum Pharmaceuticals, Inc
Medical University of South Carolina
University of Florida
Corewell Health East
McMaster University
University of Kentucky
Centre for Addiction and Mental Health
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
University of Colorado, Denver
Mayo Clinic
University Hospital, Grenoble
Saint-Joseph University
NYU Langone Health